YOLFTbeta
Protalix Biotherapeutics Inc

Protalix Biotherapeutics Inc

PLX · AMEX · Healthcare / Biotechnology

3.05USD+0.09 (+3.04%)

Price History

Full chart

Market Stats

Previous Close2.96
Open2.94
Day Range2.85 – 3.05
52-Week Range1.60 – 3.19
Volume1.59M
Market Cap219.15M
P/E (TTM)11.83
Forward P/E55.87
EPS0.23
Dividend Yield0.00%
Beta0.02
50-Day Avg2.50
200-Day Avg2.31

About

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Dror Bashan
  • Employees226
  • Headquarters2 University Plaza, Hackensack, NJ, United States, 07601, USA
  • Websitehttps://www.protalix.com

Leadership

  • Mr. Dror BashanPresident, CEO & Director · b. 1967
  • Mr. Gilad MamlokSenior VP, CFO Treasurer & Secretary · b. 1968
  • Mr. Yaron Naos B.Sc., MBASVP & COO · b. 1964
  • Ms. Yael FellousVice President of Human Resources

Financials

Income Statement

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--8.04M3.56M1---430.00K150.00K150.00K--388.00K11.24M8.39M34.42M11.51M15.16M4.36M9.20M21.08M34.24M54.69M62.90M38.35M47.64M65.49M53.40M52.74M
Growth (%)----55.76%-100.00%-----65.12%0.00%---+2797.94%-25.42%+310.49%-66.56%+31.68%-71.21%+110.79%+129.13%+62.44%+59.73%+15.00%-39.03%+24.22%+37.48%-18.47%-1.23%
Cost of Revenue--6.31M2.68M-----35.00K35.00K2.25M-3.58M4.38M1.52M8.14M5.43M9.05M730.00K8.40M15.23M9.30M10.89M10.87M16.35M19.59M22.98M24.32M27.51M
Gross Profit--1.73M871.16K1---310.00K115.00K115.00K---3.19M6.86M1.44M26.28M6.08M6.11M3.63M801.00K5.85M24.94M43.80M52.02M22.00M28.05M42.51M29.08M25.24M
Gross Margin--21.53%24.51%100.00%---72.09%76.67%76.67%---821.39%61.02%17.21%76.34%52.85%40.28%83.27%8.71%27.74%72.83%80.08%82.71%57.37%58.87%64.91%54.46%47.85%
Operating Expense--2.90M1.69M382.00K---475.58K5.90M9.82M--28.78M36.83M37.97M38.45M33.20M34.67M27.30M33.96M40.36M44.25M54.52M49.31M42.46M41.06M32.05M25.16M30.74M
Operating Income-44.06K-164.38K-1.17M-816.00K-382.00K-386.00K-166.00K-147.38K-165.58K-5.79M-9.70M-24.57M-24.17M-31.97M-29.97M-36.53M-12.17M-27.12M-28.56M-23.67M-33.16M-34.52M-19.31M-10.72M2.71M-20.46M-13.01M10.46M3.92M-5.50M
Operating Margin---14.61%-22.95%-38200000.00%----38.51%-3859.33%-6469.33%---8239.43%-266.51%-435.62%-35.36%-235.53%-188.38%-542.39%-360.51%-163.76%-56.39%-19.59%4.31%-53.36%-27.32%15.97%7.34%-10.43%
EBITDA-44.06K-164.38K-972.00K-653.00K-382.00K-292.00K-166.00K-147.38K-165.58K-5.48M-8.99M-21.79M-21.18M-29.98M-26.83M-32.90M-7.93M-23.58M-25.22M-21.18M-23.00M-71.80M-17.10M-8.69M4.45M-18.94M-10.78M12.94M6.52M-2.95M
EBITDA Margin---12.10%-18.37%-38200000.00%----38.51%-3652.00%-5994.67%---7726.55%-238.64%-392.32%-23.02%-204.79%-166.38%-485.27%-250.04%-340.62%-49.94%-15.89%7.07%-49.40%-22.63%19.75%12.21%-5.60%
Net Income131.68K118.44K-1.15M-998.00K-106.00K-329.00K-150.00K-140.71K-160.07K-5.75M-9.43M-22.48M-22.41M-31.44M-29.00M-36.53M-11.62M-27.79M-29.94M58.04M-29.36M-83.44M-26.46M-18.28M-6.52M-27.58M-14.93M8.31M2.93M-6.60M
Net Income Margin---14.27%-28.07%-10600000.00%----37.23%-3830.67%-6284.67%---8103.09%-257.90%-435.60%-33.75%-241.38%-197.51%1329.90%-319.22%-395.86%-77.27%-33.42%-10.37%-71.92%-31.33%12.69%5.49%-12.52%
R&D---------3.52M5.25M12.86M17.40M21.64M29.95M31.04M28.69M29.23M27.35M20.02M30.41M28.83M33.33M44.62M38.17M29.73M29.35M17.09M12.97M19.05M
R&D as % of Total Revenue---------2349.33%3497.33%--5576.80%266.37%370.18%83.34%253.84%180.42%458.87%330.60%136.80%97.34%81.58%60.68%77.53%61.61%26.10%24.29%36.13%
Interest Expense0051.57K0000000000529.00K968.00K2.00K34.00K674.00K4.93M3.73M4.19M9.72M7.68M7.97M9.67M7.52M2.53M3.18M1.06M1.19M
Interest Expense % of Total Revenue--0.64%0.00%0.00%---0.00%0.00%0.00%--136.34%8.61%0.02%0.10%5.85%32.55%85.59%45.57%46.14%22.44%14.56%15.38%19.61%5.31%4.86%1.99%2.26%

Balance Sheet

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.34M7.47M4.77M2.05M1.90M1.02M875.22K734.25K565.84K987.36K26.99M68.14M50.81M98.67M64.73M51.80M78.73M113.33M78.47M97.25M82.25M72.21M61.13M45.39M67.93M73.67M55.79M84.43M73.42M82.35M
Total Liabilities7.34M7.47M1.42M459.36K560.61K77.28K79.07K78.82K70.47K72.93K2.70M4.45M6.46M82.79M76.05M77.88M82.08M140.28M134.07M86.38M92.20M103.51M114.01M115.71M94.97M79.70M66.43M50.87M30.21M34.12M
Total Equity003.35M1.59M1.34M945.91K796.15K655.43K495.36K914.43K24.28M63.69M44.35M15.88M-11.32M-26.08M-3.36M-26.95M-55.60M10.87M-9.96M-31.29M-52.88M-70.32M-27.04M-6.04M-10.64M33.57M43.21M48.23M
Cash763.97K547.94K1.29M407.47K390.74K915.63K807.64K179.48K563.71K985.24K15.38M61.81M42.60M81.27M35.90M27.00M52.03M86.40M54.77M76.37M63.28M51.16M37.81M17.79M18.27M38.98M17.11M23.63M19.76M14.68M
Total Debt--64.14K57.83K-------------67.05M67.46M72.10M77.52M57.24M53.26M60.92M64.40M33.47M33.47M27.69M5.53M8.32M
Net Debt-763.97K-547.94K-1.23M-349.64K-390.74K-915.63K-807.64K-179.48K-563.71K-985.24K-15.38M-61.81M-42.60M-81.27M-35.90M-27.00M-52.03M-19.35M12.70M-4.28M14.23M1.02M10.16M43.13M46.13M-5.51M16.36M4.06M-14.23M-6.36M

Cash Flow

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-40.57K-247.92K-909.52K-1.41M-53.11K-789.43K-146.59K-136.68K-168.13K-72.47K-5.09M-10.45M-16.02M44.45M-38.46M-23.57M635.00K-30.65M-29.28M-24.28M-32.10M-9.99M-7.74M-19.36M-26.11M-10.29M-25.00M-1.32M8.67M-11.99M
Investing Cash Flow-6.32M31.89K-3.85M532.43K71.37K1.31M38.59K-491.48K552.36K--980.00K-2.44M-3.70M-6.17M-7.99M-5.87M-2.29M-2.10M-1.00M39.39M-967.00K-1.12M-591.00K-883.00K-19.95M18.92M-5.04M-16.71M4.22M-2.37M
Financing Cash Flow7.05M-5.97M-6.30K-35.00K----494.00K16.71M58.57M-51.00K293.00K501.00K20.93M26.56M66.89M46.00K6.63M19.70M-1.42M-4.75M46.47M46.47M12.08M8.24M24.67M-16.79M9.33M
Capital Expenditure00139.99K29.30K000000842.00K2.33M3.37M6.20M7.86M5.71M2.07M1.89M785.00K464.00K849.00K971.00K686.00K627.00K655.00K1.46M628.00K1.15M1.28M1.64M
Free Cash Flow-40.57K-247.92K-1.05M-1.44M-53.11K-789.43K-146.59K-136.68K-168.13K-72.47K-5.93M-12.78M-19.39M38.26M-46.32M-29.27M-1.43M-32.54M-30.07M-24.75M-32.95M-10.96M-8.43M-19.98M-26.76M-11.74M-25.63M-2.47M7.39M-13.63M
Dividends Paid---------------0000000--------
FCF to OCF100.00%100.00%115.39%102.08%100.00%100.00%100.00%100.00%100.00%100.00%116.54%122.35%121.05%86.06%120.42%124.20%-225.67%106.17%102.68%101.91%102.65%109.72%108.86%103.24%102.51%114.19%102.51%187.18%85.22%113.66%
Dividend Paid to FCF---------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateMar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Nov 28, 2007Mar 17, 2008May 6, 2008Aug 8, 2008Nov 10, 2008Mar 6, 2009May 11, 2009Aug 3, 2009Nov 9, 2009Feb 26, 2010May 10, 2010Aug 5, 2010Nov 8, 2010Feb 23, 2011May 4, 2011Aug 8, 2011Nov 7, 2011Feb 27, 2012May 9, 2012Aug 3, 2012Nov 7, 2012Feb 28, 2013May 9, 2013Aug 8, 2013Nov 7, 2013Mar 13, 2014May 8, 2014Aug 7, 2014Nov 10, 2014Mar 12, 2015May 7, 2015Aug 10, 2015Nov 9, 2015Mar 8, 2016May 9, 2016Aug 8, 2016Nov 9, 2016Mar 16, 2017May 10, 2017Aug 9, 2017Nov 8, 2017Mar 6, 2018May 9, 2018Aug 9, 2018Nov 7, 2018Mar 18, 2019May 6, 2019Aug 8, 2019Nov 7, 2019Mar 12, 2020Jun 1, 2020Aug 10, 2020Oct 29, 2020Mar 30, 2021May 14, 2021Aug 16, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Feb 27, 2023May 4, 2023Aug 7, 2023Nov 6, 2023Mar 14, 2024May 10, 2024Aug 14, 2024Nov 14, 2024Mar 12, 2025May 9, 2025Aug 14, 2025Nov 13, 2025Mar 12, 2026May 13, 2026Aug 12, 2026Nov 12, 2026
EPS Estimate--------------------------0.50-0.60-0.50-0.65-0.95-0.60-0.75-0.701.15-0.77-0.83-1.00-0.62-0.66-0.87-0.97-1.00-0.820.45-0.90-0.65-0.65-0.43-0.40-0.32-0.67-0.67-0.80-0.40-0.80-0.80-0.806.80-0.75-0.90-1.00-1.10-0.90-0.35-0.45-0.60-0.90-0.40-0.40-0.45-0.25-0.30-0.35-0.63-0.30-0.20-0.08-0.08-0.17-0.10-0.12-0.11-0.04-0.18-0.15-0.15-0.05-0.04-0.07-0.03-0.020.020.060.070.080.030.060.04-0.01-0.01-0.02
EPS Actual-4.38-1.67-1.66-1.23-1.10-1.10-1.11-1.02-1.11-1.58-0.92-2.01-1.48-1.08-0.36-0.44-1.1010.00-0.190.50-1.83-0.60-0.54-1.39-0.72-0.70-0.70-0.60-0.90-0.90-0.70-0.70-0.80-1.90-1.00-1.20-0.30-1.10-0.60-1.60-1.00-1.00-0.701.00-0.60-1.10-0.50-0.70-0.60-1.20-0.80-0.70-0.90-0.90-0.60-0.50-0.407.70-0.90-1.10-0.70-1.27-0.50-1.08-0.90-0.60-0.60-0.80-1.00-0.37-0.50-0.50-0.200.010.10-0.13-0.140.01-0.14-0.25-0.09-0.15-0.05-0.11-0.07-0.07-0.050.21-0.03-0.07-0.06-0.030.030.09-0.05-0.040.03-0.070.220.05-
Surprise--------------------------40.00%-16.67%-20.00%-38.46%5.26%-16.67%6.67%-14.29%-265.22%-29.87%-44.58%70.00%-77.42%9.09%-83.91%-3.09%0.00%14.63%122.22%33.33%-69.23%23.08%-62.79%-50.00%-275.00%-19.40%-4.48%-12.50%-125.00%25.00%37.50%50.00%13.24%-20.00%-22.22%30.00%-15.45%44.44%-208.57%-100.00%0.00%33.33%-100.00%-150.00%17.78%-100.00%-66.67%42.86%101.59%133.33%35.00%-75.00%112.50%17.65%-150.00%25.00%-36.36%-25.00%38.89%53.33%53.33%0.00%625.00%57.14%-133.33%-200.00%-250.00%-50.00%28.57%-162.50%-233.33%-50.00%-300.00%2300.00%600.00%-
Timing--------------------------After-hoursAfter-hoursAfter-hours-Pre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap219.15M
Enterprise Value194.15M
Trailing P/E11.83
Forward P/E55.87
PEG Ratio-0.10
Price / Sales2.72
Price / Book3.16
EPS0.23
Book Value0.886
Revenue (TTM)80.62M
Gross Profit (TTM)36.90M
EBITDA24.86M
Profit Margin23.50%
Operating Margin23.48%
Return on Equity31.24%
Return on Assets15.42%
Shares Outstanding80.57M
Shares Float77.45M
Beta0.02
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 11.00
  • Buy
    1

Stock Splits

  • Dec 20, 20191:10
  • Jan 3, 20071:10